Aerie Pharmaceuticals 2017 Investor Presentation

Aerie Pharmaceuticals disclosed investor presentation materials on March 7, 2017, filed as Exhibit 99.1 to Form 8-K. The company, a biotechnology firm specializing in biological products, provided slides for presentations to investors detailing company information.